- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
PCI Biotech Holding ASA (PCIB)
PCI Biotech Holding ASA stock price live, this page displays OL PCIB stock exchange data. View the PCIB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the PCI Biotech Holding ASA real time stock price chart below.
What Is the PCI Biotech Holding ASA Stock Price Today?
The PCI Biotech Holding ASA stock price today is 1.60.
What Is the Stock Symbol for PCI Biotech Holding ASA?
The stock symbol for PCI Biotech Holding ASA is ""PCIB.""
What Stock Exchange Does PCI Biotech Holding ASA Trade On?
PCI Biotech Holding ASA is listed and trades on the Oslo stock exchange.
Is PCI Biotech Holding ASA a Good Stock to Buy?
Determining whether PCI Biotech Holding ASA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PCIB quote. (ISIN: NO0010405640)
What Is the PCI Biotech Holding ASA Stock Price Today?
The PCI Biotech Holding ASA stock price today is 1.60.
What Is the Stock Symbol for PCI Biotech Holding ASA?
The stock symbol for PCI Biotech Holding ASA is ""PCIB.""
What Stock Exchange Does PCI Biotech Holding ASA Trade On?
PCI Biotech Holding ASA is listed and trades on the Oslo stock exchange.
Is PCI Biotech Holding ASA a Good Stock to Buy?
Determining whether PCI Biotech Holding ASA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PCIB quote. (ISIN: NO0010405640)
Oslo
Currency in NOK
1.60
-0.01(-0.31%)
Real-time Data·
Fair Value
An estimate of a PCI Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.44
1.68
52 wk Range
1.10
2.22
PCIB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
PCIB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a PCI Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.441.68
52 wk Range
1.102.22
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PCIB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a PCI Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
PCI Biotech Holding ASA Company Profile
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development of technologies and novel therapies through its photochemical technology platform. The company’s technology platform consists of a proprietary small molecule photosensitiser and a light source; and develops photochemical lysis (PCL) comprising light-triggered cell lysis, which enhances yield and purity in viral vector manufacturing, as well as photochemical internalisation (PCI), inducing light-triggered intracellular release for various therapeutic modalities. It also explores for intratumoural immunotherapy therapeutics that identifies novel treatment combinations to overcome resistance to immune-checkpoint inhibitors and safety-issues associated with treatments; and develops nucleic acid therapeutics to improve the treatment of dermatological diseases. PCI Biotech Holding ASA was incorporated in 2007 and is headquartered in Oslo, Norway.
PCI Biotech Holding ASA Earnings Call Summary for Q4/2024
- Q4 2024 earnings call lacked clear financial data and strategic insights, leading to a 2.5% stock dip in pre-market trading
- Revenue of $0.56 million reported for last twelve months, with 115% revenue growth, according to InvestingPro data
- Stock currently trading at $0.14, between 52-week range of $0.10 to $0.31, with 29% return over past week and 35% year-to-date gain
- No clear forward-looking guidance or strategic initiatives outlined, raising investor uncertainty about future performance
- Vague references to partnerships and public grants suggest potential operational challenges and unclear product development progress
Last Updated: 27/02/2025, 09:20
Read Full TranscriptCompare PCIB to Peers and Sector
Metrics to compare | PCIB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPCIBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.6x | −2.1x | −0.5x | |
PEG Ratio | −0.20 | 0.00 | 0.00 | |
Price/Book | 2.5x | 1.6x | 2.6x | |
Price / LTM Sales | 8.9x | 6.8x | 3.3x | |
Upside (Analyst Target) | - | 49.1% | 42.9% | |
Fair Value Upside | Unlock | 14.5% | 6.2% | Unlock |
Earnings
Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does PCI Biotech Trade On?
PCI Biotech is listed and trades on the Oslo Stock Exchange stock exchange.
What Is the Stock Symbol for PCI Biotech?
The stock symbol for PCI Biotech is "PCIB."
What Is the PCI Biotech Market Cap?
As of today, PCI Biotech market cap is 59.72M.
What Is PCI Biotech's Earnings Per Share (TTM)?
The PCI Biotech EPS (TTM) is -0.44.
When Is the Next PCI Biotech Earnings Date?
PCI Biotech will release its next earnings report on 28 Aug 2025.
From a Technical Analysis Perspective, Is PCIB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has PCI Biotech Stock Split?
PCI Biotech has split 4 times.
How Many Employees Does PCI Biotech Have?
PCI Biotech has 5 employees.
What is the current trading status of PCI Biotech (PCIB)?
As of 12 Aug 2025, PCI Biotech (PCIB) is trading at a price of 1.60, with a previous close of 1.60. The stock has fluctuated within a day range of 1.44 to 1.68, while its 52-week range spans from 1.10 to 2.22.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.